Additional file 1 of Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report

Yu-Chien Lin (Contributor)
Kuo-Chang Wen (Creator)
Pi Lin Sung (Contributor)
Yu Ting Chou (Creator)
Phui-Ly Liew (Contributor)
Lin Yu Chen (Contributor)
Rui-Lan Huang (Creator)
Hung-Cheng Lai (Contributor)
Lu-Te Chang (Contributor)

資料集

Description

Additional file 1: Supplementary Figure 1. Immunohistochemistry (IHC) of the PD-L1 control. (a) Positive control of PD-L1 staining (Dako 22C3, tonsil). (b) Positive control of PD-L1 staining (Dako 28–8, tonsil)

可用日期	2020
發行者	Figshare

DOI
10.6084/m9.figshare.13352142.v1

存取資料集

Creative Commons Attribution 4.0 International

1 文章

Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
Lin, Y. C., Wen, K. C., Sung, P. L., Chou, Y. T., Liew, P. L., Chen, L. Y., Huang, R. L., Lai, H. C. & Chang, L. T., 12月 2020, 於: Journal of Ovarian Research. 13, 1, 143.
研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取
11 連結會在新分頁中打開引文斯高帕斯（Scopus）

引用此

DataSetCite

Lin, Y. (Contributor), Wen, K. (Creator), Sung, P. (Contributor), Chou, Y. (Creator), Liew, P. (Contributor), Chen, L. (Contributor), Huang, R. (Creator), Lai, H. (Contributor), Chang, L. (Contributor) (2020). Additional file 1 of Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report. Figshare. 10.6084/m9.figshare.13352142.v1

Additional file 1 of Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report

Description

DOI

存取資料集

研究成果

Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report

引用此